tradingkey.logo
搜尋

Crescent Biopharma Ord Shs

CBIO
添加自選
14.150USD
-0.220-1.53%
收盤 11-13 16:00(美東)
525.53M總市值
虧損本益比TTM

關於 Crescent Biopharma Ord Shs 公司

Crescent Biopharma, Inc. is a biotechnology company. The Company is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Company’s lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.

Crescent Biopharma Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Crescent Biopharma Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Susan M. Moran, M.D.
Dr. Susan M. Moran, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%

常見問題

Crescent Biopharma Ord Shs的前五大股東是誰?

Crescent Biopharma Ord Shs的前五大股東如下:Dr. Jonathan Violin, Ph.D.
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有